About Lee Pharma Limited
Data last updated:
Lee Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 October 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1997PLC028095. Its GSTIN is 36AAACC8372L1ZB (Telangana). The company holds 7 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹7.65 Cr and a paid-up capital of ₹1.64 Cr. It was formerly known as Lee Pharma Private Limited. It is led by directors including Venkata Reddy Alla (Managing Director) and Alla Ratna Kumari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹928.7 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹35.52 Cr (net margin 3.8%) and EBITDA of ₹123.2 Cr (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 23% over five years.
The company has about 1,381 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lee Pharma. As per MCA filings, the company has open charges of ₹592.69 Cr and satisfied charges of ₹518.66 Cr on record. Court records list 48 cases involving the company, including 20 filed by the company and 12 filed against it; 7 cases are pending. The company has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Biocon Pharma Limited. The company has 16 MSME Form 1 returns on record between 2017 and 2024, listing 1,942 overdue payments to 84 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website leepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSurvey No.257&258/1 Door No.11 – 6/56 C Block Opp.Idpl Factory Moosapet(Village) Balan, Agar(Post), Hyderabad, Telangana, India – 500037
- IndustryPharma, API Manufacturers, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lee Pharma Limited
The main business activity of Lee Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lee Pharma Limited FY 2025 filings available
Lee Pharma Limited reported revenue of ₹928.7 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lee Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 3% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lee Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹928.7 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹123.2 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹35.52 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lee Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lee Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lee Pharma Limited
Lee Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocon Pharma Limited | •••• | •••• | •••• | •••• | 603 | Bangalore, Karnataka, India |
| Chemspec Chemicals Private Limited | •••• | •••• | •••• | •••• | 332 | Navi Mumbai, Maharashtra, India |
| Orchid Pharma Limited Listed | •••• | •••• | •••• | •••• | 1,125 | Chengalpattu, Tamil Nadu, India |
| Procter & Gamble Health Limited Listed | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Fresenius Kabi India Private Limited | •••• | •••• | •••• | •••• | 1,242 | Ranjangaon, Maharashtra, India |
| Lee Pharma Limited this company | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Punjab Chemicals and Crop Protection Limited Listed | •••• | •••• | •••• | •••• | 39 | Derabassi, Punjab, India |
| Omniactive Health Technologies Limited | •••• | •••• | •••• | •••• | 200 | Mumbai, Maharashtra, India |
| TTK Healthcare Limited Listed | •••• | •••• | •••• | •••• | 926 | Chennai, Tamil Nadu, India |
| Rubicon Research Limited | •••• | •••• | •••• | •••• | 1,191 | Thane, Maharashtra, India |
| Hindys Lab Private Limited | •••• | •••• | •••• | •••• | 285 | Chityal, Telangana, India |
Peers are the five companies nearest above and the five nearest below Lee Pharma by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Lee Pharma Limited
Lee Pharma Limited is audited by Suryanarayana Reddy & Co for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Suryanarayana Reddy & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lee Pharma Limited
Lee Pharma has 8 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alla Ratna Kumari Also directs: Lee Health Domain India Private Limited | Whole-Time Director | 27 Aug 2007 | 19 Years 1 Months | Current |
| Venkata Reddy Alla Also directs: Lee Health Domain India Private Limited | Managing Director | 06 Oct 1997 | 29 Years 0 Months | Current |
| Santosh Babu Busani Also directs: Hetero Healthcare Limited | Director | 30 Sep 2021 | 5 Years 0 Months | Current |
| Vijaykumar Raghunandanprasad Agrawal | Director | 27 Sep 2007 | 19 Years 0 Months | Current |
| Raghumitra Alla Also directs: Lee Fine Chem Private Limited | Whole-Time Director | 04 May 2006 | 20 Years 5 Months | Current |
| Dr Gopala Rao Tatineni Also directs: Vanastali Hills Real Estates Private Limited | Director | 22 Apr 1999 | 27 Years 5 Months | Current |
Ownership and Shareholding of Lee Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lee Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2025 | Others | ₹15 Cr | Open |
| 29 Mar 2025 | Others | ₹18 Cr | Open |
| 17 May 2024 | Axis Bank Limited | ₹12.5 Cr | Open |
| 19 May 2023 | Others | ₹30 Cr | Open |
| 19 May 2023 | Others | ₹5 Cr | Open |
Total charge records: 44 View all charges
Deals & Funding of Lee Pharma Limited
Lee Pharma Limited has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024.
Deals on record (5 of 15)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Rights issue | ₹27.08 Cr | Investors: R.L.Fine Chem Private Limited , 3 individuals |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: MAPE Group |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: an individual |
| Apr 2017 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: an individual |
Full deal history
All 15 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Lee Pharma Limited
Lee Pharma Limited has 48 court cases on record: 20 filed by Lee Pharma, 12 filed against it, 16 where it is another party. 7 cases are pending and 41 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 30 | 8 | 4 |
| District courts | 18 | 4 | 3 |
Cases on record (5 of 48)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed against the company by Trireme Life Sciences Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Vimal Drugs Private Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Incyte Holdings Corporation & Ors | Pending |
| High Court of Andhra Pradesh | Court case (WP(PIL)) | Company is another party | Pending |
| District court, Hyderabad CCC, Telangana | Court case (MVOP) | Company is another party | Pending |
Full case history
All 48 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Lee Pharma Limited
Lee Pharma Limited has 16 MSME Form 1 returns on record between 2017 and 2024, listing 1,942 overdue payments to 84 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 84)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Sai Siri Packaging Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 16 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Lee Pharma Limited
Lee Pharma operates one associated brand: Lee Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms | leepharma.com |
Employees and EPFO Compliance at Lee Pharma Limited
Lee Pharma Limited has a workforce of 1,381 employees as of Oct 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Lee Pharma Limited
Lee Pharma has one previous CIN (Corporate Identification Number): U24230AP1997PLC028095. The current CIN is U24230TG1997PLC028095, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1997PLC028095 | Current |
| U24230AP1997PLC028095 | Previous |
News related to Lee Pharma Limited
Recent Activity on Lee Pharma Limited
Lee Pharma Limited has 18 board changes on record since 1997: 13 appointments and 5 cessations. The latest: Ramaseshappa Siva Prasad Panchangam was appointed as Director on 30 Sep 2024.
97 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Lee Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lee Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lee Pharma Limited
Lee Pharma has 7 GST registrations: 5 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACC8372L1ZB | Telangana | Active | 01 Jul 2017 |
| 36AAACL3435F1ZT | Telangana | Active | 01 Jul 2017 |
| 36AAACL3435F2ZS | Telangana | Active | 24 Aug 2020 |
| 37AAACL3435F1ZR | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lee Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lee Pharma Limited
Lee Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 October 1997 (29+ years old) and is registered under CIN U24230TG1997PLC028095.
Lee Pharma reported revenue of ₹928.7 Cr for FY 2025 (up 3% YoY).
Lee Pharma has 8 current directors:
- Venkata Reddy Alla - Managing Director
- Alla Ratna Kumari - Whole-Time Director
- Raghumitra Alla - Whole-Time Director
- Santosh Babu Busani - Director
- Vijaykumar Raghunandanprasad Agrawal - Director
- Dr Gopala Rao Tatineni - Director
- Ramaseshappa Siva Prasad Panchangam - Director
- Anil Jain - Nominee Director
Lee Pharma reported a net profit of ₹35.52 Cr (net margin 3.8%) and EBITDA of ₹123.2 Cr (EBITDA margin 13.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lee Pharma is 13% over three years and 23% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lee Pharma is 36AAACC8372L1ZB, registered in Telangana. The company has 7 GST registrations in all, of which 5 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAACL3435F1ZT (Telangana), 36AAACL3435F2ZS (Telangana), 37AAACL3435F1ZR (Andhra Pradesh).
The CIN (Corporate Identification Number) of Lee Pharma is U24230TG1997PLC028095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lee Pharma has 48 court cases on record: 20 filed by the company and 12 filed against it. 7 are pending. Most are in the high courts.
Lee Pharma was incorporated on 06 October 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lee Pharma has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024.
The peers of Lee Pharma by revenue are Biocon Pharma Limited, Chemspec Chemicals Private Limited, Orchid Pharma Limited, Procter & Gamble Health Limited, Fresenius Kabi India Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Formulations).
Ramaseshappa Siva Prasad Panchangam was appointed as Director on 30 Sep 2024. Anil Jain was appointed as Nominee Director on 29 Jul 2023. Vishakha Bhupendra Dhablia ceased to be Director on 29 Jul 2023. Lee Pharma has 18 board changes on record in total.